Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …

This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …

Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that
progressively impact the interstitium, resulting in compromised gas exchange …

Ethnopharmacological relevance Interstitial lung disease (ILD) is a chronic lung dysfunction
disease with a poor prognosis and poor recovery. The clinically used therapeutic drugs …

Importance Pulmonary fibrosis (PF) is characterized by progressive scarring of lung tissue
and poor survival. Racial and ethnic minority populations face the greatest risk of morbidity …

Idiopathic pulmonary fibrosis (IPF) is a long-lasting, continuously advancing, and irrevocable
interstitial lung disorder with an obscure origin and inadequately comprehended …

Organ fibrosis is a serious health challenge worldwide, and its global incidence and medical
burden are increasing dramatically each year. Fibrosis can occur in nearly all major organs …

Abstract Background Interstitial lung diseases (ILDs) cause fibrosis of lung parenchyma,
leading to impaired quality of life, dyspnea, and functional decline. Individuals with ILD …

Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial
morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated …

Background: In patients with interstitial lung disease (ILD), decreased oxygen saturation
(SpO2) reduces physical performance and causes exertional dyspnea. Portable oxygen …